Method of selecting aptamers
View Patent ↗The present invention is a method for the identification of one or more aptamers to at least one target molecule, the method comprising: selecting candidate aptamer sequences that bind to a target molecule, assigning to the bound sequences a measure (fitness function) of each sequence's aptameric potential, allowing evolution of some or all of the sequences to create a new mixture of candidate sequences, and repeating the method with the newly created candidate aptamer pool until the aggregate aptameric potential of the candidate pool reaches a plateau, wherein sequences present in the final pool are optimal aptamers to the target molecule.
1. A method for the identification of at least one aptamer to at least one target molecule, the method comprising:
a) contacting a pool of candidate aptamer sequences with the at least one target molecule;
b) partitioning unbound sequences from those sequences that have bound specifically to the at least one target molecule;
c) dissociating the sequence-target complexes to obtain a ligand-enriched mixture of sequences;
d) assigning to each sequence obtained in step c) a measure of the sequence's potential as an aptamer, wherein the measure comprises a fitness function;
e) using the measure of step d) to determine the aptameric potential of the ligand-enriched mixture;
f) allowing evolution of some or all of the sequences obtained in step c) using information obtained in step e) to create a new candidate aptamer pool; and
g) repeating the steps a) to f) using the new candidate aptamer pool created in step f) as the input pool of candidate aptamer sequences in the next iteration of step a) until the aggregate aptameric potential of the candidate pool reaches a plateau, wherein sequences present in the final candidate aptamer pool are optimal aptamers to the at least one target molecule, thereby identifying the at least one aptamer.
2. A method according to claim 1 , wherein the at least one target molecule is a protein.
3. A method according to claim 1 , wherein the at least one target molecule is a single, isolated protein.
4. A method according to claim 1 , wherein the identity of one or more of the at least one target molecule is known.
5. A method according to claim 1 , wherein the at least one target molecule comprises multiple proteins in a mixture of proteins.
6. A method according to claim 1 , wherein the at least one target molecule is a known protein present in a mixture of proteins.
7. A method according to claim 5 , wherein the mixture of proteins is derived from a biological sample.
8. A method according to claim 7 , wherein the biological sample is a bodily fluid.
9. A method according to claim 8 , wherein the bodily fluid is blood or derived from blood.
10. A method according to claim 8 , wherein the bodily fluid comprises serum or plasma.
11. A method according to claim 1 , wherein the aptamer sequence comprises DNA, RNA, PNA (peptide nucleic acid), or variants or combinations thereof.
12. A method according to claim 1 , wherein the aptamer is between a 30mer and a 60mer.
13. A method according to claim 1 , wherein the aptamer is a 40mer.
14. A method according to claim 1 , wherein the aptameric potential is measured by quantifying the candidate sequences in the ligand-enriched mixture.
15. A method according to claim 14 , wherein the quantification step is carried out by sequencing at least part of each candidate sequence.
16. A method according to claim 15 , wherein the sequencing step is carried out on a single molecule array or a clonal single molecule array.
17. A method according to claim 1 , the method further comprising arraying sequences in the ligand-enriched mixture onto a surface before step d).
18. A method according to claim 17 , wherein the method further comprises amplifying the arrayed sequences.
19. A method according to claim 1 , wherein the measure of aptameric potential further includes at least one measured, calculated or bioinformatic property.
20. A method according to claim 19 , wherein the bioinformatic property comprises secondary structure prediction, tertiary structure prediction, self-similarity, informational complexity, similarity to known aptamer sequences, sequence motifs or combinations thereof.
21. A method according to claim 1 , wherein members of the ligand-enriched mixture of sequences having an aptameric potential of greater statistical significance, as compared to the entire ligand-enriched mixture of sequences, are progressed from steps d) and e) to step f).
22. A method according to claim 1 , wherein the ligand-enriched sequences having an aptameric potential falling in a mean or upper percentile range are progressed from steps d) and e) to step f).
23. A method according to claim 1 , wherein the ligand-enriched sequences having a statistically insignificant aptameric potential are removed from the candidate pool.
24. A method according to claim 1 , wherein non-binding candidate sequences are eluted and discarded from the candidate pool.
25. A method according to claim 1 , wherein the method further comprises removing numerically dominant sequences from the candidate pool.
26. A method according to claim 1 , wherein the method further comprises obtaining the full sequence of the candidate aptamers present in the final pool.
27. A method according to claim 1 , wherein members of the ligand-enriched mixture of sequences having an aptameric potential of greater statistical significance as compared to the entire ligand-enriched mixture of sequences, or motifs derived from such sequences, are used to design new candidate aptamer pools.
28. A method according to claim 1 , wherein members of the ligand-enriched mixture of sequences, and/or motifs thereof, having an aptameric potential of greater statistical significance, as compared to the entire ligand-enriched mixture of sequences, are used to influence random changes to and/or recombination of sequences showing a high aptameric potential.
29. A method according to claim 1 , wherein the method further comprises modifying candidate sequences to increase stability and/or binding potential.